Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
KM Kew, A Seniukovich - Cochrane Database of Systematic …, 2014 - cochranelibrary.com
Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
S Leucht, S Hierl, W Kissling, M Dold… - The British Journal of …, 2012 - cambridge.org
BackgroundThe efficacy of psychopharmacological treatments has been called into
question. Psychiatrists are unfamiliar with the effectiveness of common medical drugs …
question. Psychiatrists are unfamiliar with the effectiveness of common medical drugs …
Guidelines for the management of adult lower respiratory tract infections‐Full version
M Woodhead, F Blasi, S Ewig, J Garau… - Clinical microbiology …, 2011 - Wiley Online Library
Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …
Guidelines published in 2005 and now includes scientific publications through to May 2010 …
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American …
A Qaseem, TJ Wilt, SE Weinberger… - Annals of internal …, 2011 - acpjournals.org
Description: This guideline is an official statement of the American College of Physicians
(ACP), American College of Chest Physicians (ACCP), American Thoracic Society (ATS) …
(ACP), American College of Chest Physicians (ACCP), American Thoracic Society (ATS) …
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma
BACKGROUND: Improvement in lung function after macrolide antibiotic therapy has been
attributed to reduction in bronchial infection by specific bacteria. However, the airway might …
attributed to reduction in bronchial infection by specific bacteria. However, the airway might …
Chronic obstructive pulmonary disease and comorbidities
M Decramer, W Janssens - The Lancet Respiratory Medicine, 2013 - thelancet.com
Results of epidemiological studies have shown that chronic obstructive pulmonary disease
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
A Singanayagam, N Glanville, JL Girkin… - Nature …, 2018 - nature.com
Inhaled corticosteroids (ICS) have limited efficacy in reducing chronic obstructive pulmonary
disease (COPD) exacerbations and increase pneumonia risk, through unknown …
disease (COPD) exacerbations and increase pneumonia risk, through unknown …
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
IA Yang, MS Clarke, EHA Sim… - Cochrane Database of …, 2012 - cochranelibrary.com
Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …
disease (COPD) has been the subject of much controversy. Major international guidelines …
[HTML][HTML] Women and COPD: do we need more evidence?
C Gut-Gobert, A Cavaillès, A Dixmier… - European …, 2019 - Eur Respiratory Soc
The increasingly female face of chronic obstructive pulmonary disease (COPD) prevalence
among women has equalled that of men since 2008, due in part to increased tobacco use …
among women has equalled that of men since 2008, due in part to increased tobacco use …